Amneal Pharmaceuticals has announced positive topline results from the phase 3 RISE-PD trial evaluating a novel formulation of carbidopa/levodopa for patients with Parkinson’s disease (PD) who have ...
Medications for Parkinson’s may help replenish dopamine levels or mimic its effects, addressing the deterioration of brain cells that produce this neurotransmitter. Carbidopa-levodopa is commonly the ...
CHICAGO — An investigational first-in-class oral selective partial D1/D5 dopamine receptor agonist was associated with delayed need for levodopa or dose escalation in patients with Parkinson’s disease ...
Prof. Joachim Loo (left) and LiberaTx CEO Dr. Shashi Kesavapany holding engineered pill samples. Photo credit: NTU Singapore Drug developers from Singapore are set to test a levodopa pill designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results